Inhibitors of biotin protein ligase: A new class of antibiotic targetting Staphylococcus aureus [ 2011 - 2014 ]

Research Grant

Researchers: Prof Andrew Abell (Principal investigator) ,  Dr Steven Polyak ,  Prof Grant Booker ,  Prof John Turnidge ,  Prof John Wallace
View all 6 related researchers

Brief description The rise of drug-resistant "superbugs" is a major healthcare concern in hospitals around the world. New antibiotics are needed to combat infections caused by bacteria that are resistant to current drugs. One collaborative team of researchers is addressing this issue. They have discovered a new drug effective against Staphylococcus aureus, the cause of Golden Staph using a combination of scientific disciplines the team is now moving forward and improving their exciting new drug.

Funding Amount $AUD 605,962.99

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant